Search

Your search keyword '"Agrò, Enrico Finazzi"' showing total 155 results
Start Over Author "Agrò, Enrico Finazzi"
155 results on '"Agrò, Enrico Finazzi"'

4. MP46-14 URODYNAMIC EVALUATION INFLUENCE PATIENTS SATISFACTION AND REGRET AFTER BPH SURGERY

Author

Guercio, Alessandro, primary, Lombardo, Riccardo, additional, Franco, Giorgio, additional, Secco, Silvia, additional, Pastore, Antonio, additional, Al Salhi, Yazan, additional, Cicione, Antonio, additional, Nacchia, Antonio, additional, Carbone, Antonio, additional, Fuschi, Andrea, additional, Valenzi, Fabio Maria, additional, Candita, Giuseppe, additional, Fiori, Cristian, additional, Porpiglia, Francesco, additional, Quarà, Alberto, additional, Tema, Giorgia, additional, Guarnotta, Giuseppe, additional, Sciarra, Alessandro, additional, Agrò, Enrico Finazzi, additional, Tubaro, Andrea, additional, and De Nunzio, Cosimo, additional

Published
2024
Full Text
View/download PDF

7. Videourodynamic in Children

Author

Iacovelli, Valerio, Farullo, Giuseppe, Turbanti, Andrea, Agrò, Enrico Finazzi, Soligo, Marco, Series Editor, Mosiello, Giovanni, editor, Del Popolo, Giulio, editor, Wen, Jian Guo, editor, and De Gennaro, Mario, editor

Published
2018
Full Text
View/download PDF

9. bTUNED : transcutaneous tibial nerve stimulation for neurogenic lower urinary tract

Author

Stalder, Stephanie A., primary, Gross, Oliver, additional, Anderson, Collene E., additional, Bachmann, Lucas M., additional, Baumann, Sarah, additional, Birkhäuser, Veronika, additional, Bywater, Mirjam, additional, del Popolo, Giulio, additional, Engeler, Daniel S., additional, Agrò, Enrico Finazzi, additional, Friedl, Susanne, additional, Grilo, Nuno, additional, Kiss, Stephan, additional, Koschorke, Miriam, additional, Leitner, Lorenz, additional, Liechti, Martina D., additional, Mehnert, Ulrich, additional, Musco, Stefania, additional, Sadri, Helen, additional, Stächele, Lara, additional, Tornic, Jure, additional, van der Lely, Stéphanie, additional, Wyler, Stephen, additional, and Kessler, Thomas M., additional

Published
2023
Full Text
View/download PDF

11. 49 - Does overactive bladder impact on erectile function and sexual quality of life? A single cohort analysis

Author

Iacovelli, Valerio, primary, Carilli, Marco, additional, Signoretti, Marta, additional, Cipriani, Chiara, additional, Petta, Filomena, additional, Bertolo, Riccardo, additional, Maiorino, Francesco, additional, Antonucci, Michele, additional, Vittori, Matteo, additional, Agrò, Enrico Finazzi, additional, and Bove, Pierluigi, additional

Published
2023
Full Text
View/download PDF

12. 50 - TransPerineal Laser Ablation for low- and intermediate risk prostate cancer: Short-term functional outcomes

Author

Iacovelli, Valerio, primary, Carilli, Marco, additional, Signoretti, Marta, additional, Cipriani, Chiara, additional, Petta, Filomena, additional, Bertolo, Riccardo, additional, Maiorino, Francesco, additional, Antonucci, Michele, additional, Vittori, Matteo, additional, Agrò, Enrico Finazzi, additional, and Bove, Pierluigi, additional

Published
2023
Full Text
View/download PDF

18. 70 - Italian national big data on urodynamics: Relationship between clinical and urodynamics diagnosis

Author

Rubilotta, Emanuele, primary, Ditonno, Francesco, additional, Balzarro, Matteo, additional, Gubbiotti, Marilena, additional, Ammirati, Enrico, additional, Chierchia, Stefania, additional, Masiello, Giuseppe, additional, Manodoro, Stefano, additional, Bevacqua, Marianna, additional, Fragalà, Eugenia, additional, Carone, Roberto, additional, De Rienzo, Gaetano, additional, Agrò, Enrico Finazzi, additional, Gemma, Luca, additional, Giannone, Sofia, additional, Lamartina, Marcello, additional, Marzi, Vincenzo Li, additional, Martino, Leonardo, additional, Musco, Stefania, additional, Russo, Eleonora, additional, Spilotros, Marco, additional, and Mancini, Vito, additional

Published
2023
Full Text
View/download PDF

20. MP56-08 A NOVEL URODYNAMIC SCORING SYSTEM TO ASSESS CONTINENCE QUALITY OUTCOMES OF ILEAL ORTHOTOPIC NEOBLADDERS

Author

Anceschi, Umberto, primary, Di Maida, Fabrizio, additional, Prata, Francesco, additional, Lambertini, Luca, additional, Spicchiale, Claudia Fede, additional, Mattioli, Manuela, additional, Cadenar, Anna, additional, Brassetti, Aldo, additional, Nardoni, Samuele, additional, Tuderti, Gabriele, additional, Valastro, Francesca, additional, Ferriero, Mariaconsiglia, additional, Bacchiani, Mara, additional, Bove, Alfredo Maria, additional, Salamone, Vincenzo, additional, Mastroianni, Riccardo, additional, Giudici, Sofia, additional, Misuraca, Leonardo, additional, Grosso, Antonio Andrea, additional, Mari, Andrea, additional, Tuccio, Agostino, additional, Agrò, Enrico Finazzi, additional, De Nunzio, Cosimo, additional, Minervini, Andrea, additional, and Simone, Giuseppe, additional

Published
2023
Full Text
View/download PDF

21. bTUNED: transcutaneous tibial nerve stimulation for neurogenic lower urinary tract dysfunction

Author

Stalder, Stephanie A; https://orcid.org/0000-0002-7914-8264, Gross, Oliver; https://orcid.org/0000-0002-3330-5623, Anderson, Collene E; https://orcid.org/0000-0002-4350-6816, Bachmann, Lucas M; https://orcid.org/0000-0002-9868-154X, Baumann, Sarah, Birkhäuser, Veronika; https://orcid.org/0000-0002-6646-7266, Bywater, Mirjam, Del Popolo, Giulio; https://orcid.org/0000-0002-1202-6078, Engeler, Daniel S; https://orcid.org/0000-0003-1383-4701, Agrò, Enrico Finazzi; https://orcid.org/0000-0002-0308-8824, Friedl, Susanne; https://orcid.org/0000-0001-8686-8537, Grilo, Nuno; https://orcid.org/0000-0002-7188-972X, Kiss, Stephan, Koschorke, Miriam; https://orcid.org/0000-0001-5667-0474, Leitner, Lorenz; https://orcid.org/0000-0001-5764-3494, Liechti, Martina D; https://orcid.org/0000-0002-3024-0975, Mehnert, Ulrich; https://orcid.org/0000-0001-7963-8477, Musco, Stefania; https://orcid.org/0000-0001-5844-5684, Sadri, Helen, Stächele, Lara; https://orcid.org/0000-0002-9723-0595, Tornic, Jure; https://orcid.org/0000-0002-1831-4783, van der Lely, Stéphanie; https://orcid.org/0000-0002-2688-9042, Wyler, Stephen, Kessler, Thomas M; https://orcid.org/0000-0002-1991-5919, Stalder, Stephanie A; https://orcid.org/0000-0002-7914-8264, Gross, Oliver; https://orcid.org/0000-0002-3330-5623, Anderson, Collene E; https://orcid.org/0000-0002-4350-6816, Bachmann, Lucas M; https://orcid.org/0000-0002-9868-154X, Baumann, Sarah, Birkhäuser, Veronika; https://orcid.org/0000-0002-6646-7266, Bywater, Mirjam, Del Popolo, Giulio; https://orcid.org/0000-0002-1202-6078, Engeler, Daniel S; https://orcid.org/0000-0003-1383-4701, Agrò, Enrico Finazzi; https://orcid.org/0000-0002-0308-8824, Friedl, Susanne; https://orcid.org/0000-0001-8686-8537, Grilo, Nuno; https://orcid.org/0000-0002-7188-972X, Kiss, Stephan, Koschorke, Miriam; https://orcid.org/0000-0001-5667-0474, Leitner, Lorenz; https://orcid.org/0000-0001-5764-3494, Liechti, Martina D; https://orcid.org/0000-0002-3024-0975, Mehnert, Ulrich; https://orcid.org/0000-0001-7963-8477, Musco, Stefania; https://orcid.org/0000-0001-5844-5684, Sadri, Helen, Stächele, Lara; https://orcid.org/0000-0002-9723-0595, Tornic, Jure; https://orcid.org/0000-0002-1831-4783, van der Lely, Stéphanie; https://orcid.org/0000-0002-2688-9042, Wyler, Stephen, and Kessler, Thomas M; https://orcid.org/0000-0002-1991-5919

Abstract

OBJECTIVE To present the protocol for a randomized controlled trial (RCT) evaluating the efficacy and safety of transcutaneous tibial nerve stimulation (TTNS) for refractory neurogenic lower urinary tract dysfunction (NLUTD). STUDY DESIGN AND RESULTS bTUNED (bladder and TranscUtaneous tibial Nerve stimulation for nEurogenic lower urinary tract Dysfunction) is an international multicentre, sham-controlled, double-blind RCT investigating the efficacy and safety of TTNS. The primary outcome is success of TTNS, defined as improvements in key bladder diary variables at study end compared to baseline values. The focus of the treatment is defined by the Self-Assessment Goal Achievement (SAGA) questionnaire. Secondary outcomes are the effect of TTNS on urodynamic, neurophysiological, and bowel function outcome measures, as well as the safety of TTNS. CONCLUSIONS A total of 240 patients with refractory NLUTD will be included and randomized 1:1 into the verum or sham TTNS group from March 2020 until August 2026. TTNS will be performed twice a week for 30 min during 6 weeks. The patients will attend baseline assessments, 12 treatment visits and follow-up assessments at the study end.

Published
2023

23. bTUNED: transcutaneous tibial nerve stimulation for neurogenic lower urinary tract dysfunction

Author

Stalder, Stephanie A, Gross, Oliver, Anderson, Collene E, Bachmann, Lucas M, Baumann, Sarah, Birkhäuser, Veronika, Bywater, Mirjam, Del Popolo, Giulio, Engeler, Daniel S, Agrò, Enrico Finazzi, Friedl, Susanne, Grilo, Nuno, Kiss, Stephan, Koschorke, Miriam, Leitner, Lorenz, Liechti, Martina D, Mehnert, Ulrich, Musco, Stefania, Sadri, Helen, Stächele, Lara, Tornic, Jure, van der Lely, Stéphanie, Wyler, Stephen, Kessler, Thomas M, and University of Zurich

Subjects
610 Medicine & health, 10046 Balgrist University Hospital, Swiss Spinal Cord Injury Center
Published
2023
Full Text
View/download PDF

25. Reply to "Lower urinary tract (LUT) symptoms like over‐ (OAB) or underactive bladder (UAB) often are caused by pelvic organ prolapse (POP) in women and can often be cured by ligamentous POP‐repair".

Author

Agrò, Enrico Finazzi, Serati, Maurizio, and Mancini, Vito

Subjects
PELVIC organ prolapse, URINARY organs, SYMPTOMS, BLADDER, OVERACTIVE bladder, SURGICAL site infections, URINATION disorders
Abstract

This article discusses the association between pelvic organ prolapse (POP) and symptoms of overactive bladder (OAB) or underactive bladder (UAB) in women. While the exact cause of OAB in women with POP is not fully understood, surgical correction of POP can improve OAB symptoms in many patients. However, there is also a risk of developing OAB after these procedures. The severity or site of the prolapse does not appear to correlate with the prevalence or progression of OAB symptoms. Urodynamic evaluation is useful in patients with POP and concomitant OAB, as detrusor overactivity before surgery is a significant risk factor for the persistence of OAB after POP repair. The article also mentions that the relationship between POP and detrusor underactivity is discussed in another part of the paper. [Extracted from the article]

Published
2024
Full Text
View/download PDF

29. Can urethral re-bulking improve the outcomes of a prior urethral bulking?

Author

Giammò, Alessandro, primary, Ammirati, Enrico, additional, Geretto, Paolo, additional, Manassero, Alberto, additional, Squintone, Luisella, additional, Falcone, Marco, additional, Del Popolo, Giulio, additional, Pistolesi, Donatella, additional, Risi, Oreste, additional, Costantini, Elisabetta, additional, Giannantoni, Antonella, additional, Mancini, Vito, additional, Marzi, Vincenzo Li, additional, Agrò, Enrico Finazzi, additional, Pastorello, Mauro, additional, Musco, Stefania, additional, and Gontero, Paolo, additional

Published
2022
Full Text
View/download PDF

34. The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis.

Author

Scimeca, Manuel, Montanaro, Manuela, Bonfiglio, Rita, Anemona, Lucia, Agrò, Enrico Finazzi, Asimakopoulos, Anastasios D., Bei, Roberto, Manzari, Vittorio, Urbano, Nicoletta, Giacobbi, Erica, Servadei, Francesca, Bonanno, Elena, Schillaci, Orazio, and Mauriello, Alessandro

Subjects
METASTASIS, PROSTATE cancer, PROSTATE cancer patients, DISEASE risk factors, PROSTATE biopsy
Abstract

The main aim of this study was to investigate the risk of prostate cancer metastasis formation associated with the expression of ETS homologous factor (EHF) in a cohort of bioptic samples. To this end, the expression of EHF was evaluated in a cohort of 152 prostate biopsies including primary prostate cancers that developed metastatic lesions, primary prostate cancers that did not develop metastasis, and benign lesions. Data here reported EHF as a candidate immunohistochemical prognostic biomarker for prostate cancer metastasis formation regardless of the Gleason scoring system. Indeed, our data clearly show that primary lesions with EHF positive cells ≥40% had a great risk of developing metastasis within five years from the first diagnosis. Patients with these lesions had about a 40-fold increased risk of developing metastasis as compared with patients with prostate lesions characterized by a percentage of EHF positive cells ≤30%. In conclusion, the immunohistochemical evaluation of EHF could significantly improve the management of prostate cancer patients by optimizing the diagnostic and therapeutic health procedures and, more important, ameliorating the patient's quality of life. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

37. MP20-10 Efficacy and patient reported outcomes in patients undergoing BPH surgery with large prostates.

Author

Fuschi, Andrea, Guercio, Alessandro, Lombardo, Riccardo, Franco, Giorgio, Secco, Silvia, Pastore, Antonio, Al Salhi, Yazan, Cicione, Antonio, Nacchia, Antonio, Valenzi, Fabio Maria, Candita, Giuseppe, Porpiglia, Francesco, Fiori, Cristian, Quarà, Alberto, Agrò, Enrico Finazzi, Guarnotta, Giuseppe, Carbone, Antonio, Tubaro, Andrea, De Nunzio, Cosimo, and Tema, Giorgia

Subjects
PATIENT reported outcome measures, PROSTATE surgery
Published
2024
Full Text
View/download PDF

38. Evaluation of the effect of 100U of Onabotulinum toxin A on detrusor contractility in women with idiopathic OAB: A multicentre prospective study.

Author

De Rienzo, Gaetano, Minafra, Paolo, Iliano, Ester, Agrò, Enrico Finazzi, Serati, Maurizio, Giammò, Alessandro, Bianchi, Francesco Paolo, Costantini, Elisabetta, and Ditonno, Pasquale

Subjects
BOTULINUM A toxins, BOTULINUM toxin, URINATION disorders, FISHER exact test, INTERMITTENT urinary catheterization, INTRAVESICAL administration, CYSTOMETRY
Abstract

Aims: Intradetrusor injection of Onabotulinum Toxin A (BTX‐A) is a third‐line treatment for overactive bladder (OAB). Voiding dysfunction and the need for intermittent catheterization are potential complications, consequent to bladder contractility (BC) decrement. Primary aim: to evaluate BC variation after BTX‐A detrusor injection in women with idiopathic OAB. Methods: A prospective multi‐institutional observational study was conducted. Medical history, bladder diary, 24‐h pad test, and invasive urodynamic parameters were recorded before and 4–6 weeks after BTX‐A 100U administration. BC was measured as Modified Projected Isovolumetric Pressure (PIP1), that is, maximum flow rate (Qmax) + detrusor pressure at Qmax (PdetQmax). Continuous variables were expressed as median and interquartile range. We compared continuous variables using Wilcoxon test and proportions between two times with Fisher exact test. Results: No changes in PIP1 were observed (p > 0.05) in 45 women enrolled between January 2018 and September 2019. Median age was 54.6 years. At baseline, 91.1% had urge urinary incontinence, with 4.9 ± 2.6 daily pads used and a 24‐h pad test of 205.4 ± 70.8 g. Baseline detrusor contractility was normal in all the patients. Postoperatively, an improvement in the 24‐h pad test (p < 0.01), daily voids (p < 0.01), and nocturia (p < 0.01) occurred. Urodynamics pointed out a significant reduction of detrusor overactivity rate (p < 0.01) and an increase of median maximum cystometric capacity (p < 0.01). No difference was observed in median Qmax (p > 0.05), PdetQmax (p > 0.05), and PVR (p > 0.05). No patient needed postoperative catheterization. Conclusions: The current series provides evidence that detrusor injection of botulinum toxin is an effective option for treating OAB, without causing voiding dysfunction and BC impairment. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

39. PD06-07 CLINICAL AND URODYNAMIC CHARACTERIZATION OF WOMEN AFFECTED BY MIXED URINARY INCONTINENCE

Author

Giannantoni*, Antonella, primary, Gubbiotti, Marilena, additional, Rubilotta, Emanuele, additional, Balzarro, Matteo, additional, Pivetta, Lorenzo, additional, Balsamo, Raffaele, additional, Pastore, Antonio Luigi, additional, Carbone, Antono, additional, Mancini, Vito, additional, Carrieri, Giuseppe, additional, Agrò, Enrico Finazzi, additional, and Bini, Vittorio, additional

Published
2020
Full Text
View/download PDF

43. Supplemental_Material – Supplemental material for Bowel Outcome Prediction After Traumatic Spinal Cord Injury: Longitudinal Cohort Study

Author

Pavese, Chiara, Bachmann, Lucas M., Schubert, Martin, Curt, Armin, Mehnert, Ulrich, Schneider, Marc P., Scivoletto, Giorgio, Agrò, Enrico Finazzi, Maier, Doris, Abel, Rainer, Weidner, Norbert, Rupp, Rüdiger, Kessels, Alfons G., and Kessler, Thomas M.

Subjects
FOS: Clinical medicine, 110308 Geriatrics and Gerontology, 110904 Neurology and Neuromuscular Diseases, Neuroscience
Abstract

Supplemental material, Supplemental_Material for Bowel Outcome Prediction After Traumatic Spinal Cord Injury: Longitudinal Cohort Study by Chiara Pavese, Lucas M. Bachmann, Martin Schubert, Armin Curt, Ulrich Mehnert, Marc P. Schneider, Giorgio Scivoletto, Enrico Finazzi Agrò, Doris Maier, Rainer Abel, Norbert Weidner, Rüdiger Rupp, Alfons G. Kessels and Thomas M. Kessler in Neurorehabilitation and Neural Repair

Published
2019
Full Text
View/download PDF

48. Phamacological treatment of persistant lower urinary tract symptoms after a transurethral resection of the prostate is predictive of a new surgical treatment: 10 years follow‐up study.

Author

Nunzio, Cosimo De, Franco, Antonio, Lombardo, Riccardo, Baldassarri, Valeria, Borghesi, Alessandro, Li Marzi, Vincenzo, Trucchi, Alberto, Agrò, Enrico Finazzi, and Tubaro, Andrea

Subjects
TRANSURETHRAL prostatectomy, URINARY organs, BENIGN prostatic hyperplasia, PROSTATE-specific antigen, PREOPERATIVE risk factors, URETHRAL obstruction, SYMPTOMS
Abstract

Aim: To evaluate possible risk factors of re intervention in patients with benign prostatic enlargement (BPE) undergoing transurethral resection of the prostate (TURP). Materials and Methods: A consecutive series of patients with LUTS and BPE underwent TURP in our center in 2004 and 2005 and they were then followed up to September 2016. Patients were assessed at baseline, 3‐, 6‐month postoperatively and yearly thereafter with medical history, international prostate symptom score, prostate specific antigen, maximal urinary flow rate, post void residual urine. Reoperation was defined as the requirement of a new TURP to relieve bothersome LUTS. Cox regression was used to determine covariates associated with reoperation rate and the Kaplan–Meier curve assessed the time to reoperation. Results: Overall, 92 patients were enrolled. Median follow up was 142 months. 13 patients underwent a second TURP during the follow‐up period (reoperation rate was 14%); out of them 9/13 (69%) received medical treatment for persistent LUTS (p =.001). The need of LUTS/BPE pharmacological treatment after TURP is an independent risk factor for a second surgical procedure (odds ratio 9,3; p =.001). Out of the 13 patients treated with a re‐TURP, 12 (92%) underwent surgery within 5 years of follow‐up. Conclusion: In our single center study, the need of LUTS/BPE pharmacological treatment was a predictive factor of a re‐TURP. Considering that more than 90% of re‐TURP were performed during the first 5 years of follow‐up, it is assumable that a follow‐up longer than 5 years is not needed in these patients. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

49. Preoperative abdominal straining in uncomplicated stress urinary incontinence: is there a correlation with voiding dysfunction and de novo overactive bladder after mid-urethral sling procedures?

Author

Lacovelli, Valerio, Serati, Maurizio, Bianchi, Daniele, Braga, Andrea, Turbanti, Andrea, and Agrò, Enrico Finazzi

Abstract

Objectives: To evaluate the role of preoperative abdominal straining in predicting de novo overactive bladder (OAB) and voiding dysfunction in female patients undergoing suburethral taping by trans-obturator approach (TVT-O) for uncomplicated stress urinary incontinence (SUI). Methods: Data from patients who underwent TVT-O surgery for SUI were retrospectively analyzed. Inclusion criteria included: history of pure SUI. Exclusion criteria included previous surgery for urinary incontinence, pelvic radiation, pelvic surgery within the last 3 months, and anterior or apical pelvic organ prolapse (POP) ⩾ +1 cm. Voiding dysfunction has been defined through symptoms and or urodynamics (UDS) signs. Accordingly, patients were divided into group A and group B according to the presence of abdominal straining during UDS. Patients were observed clinically and with UDS at a 3-year follow-up. Results: A total of 192 patients underwent TVT-O surgery for uncomplicated SUI. Preoperative abdominal straining was identified in 60/192 patients (Group A: 31.2% vs Group B: 68.8%). Qmax was not different in the two groups (Group A: 19.5 vs Group B: 20.5 mL/s, p = 0.76). Demographics was similar for the two groups regarding age, parity. At 3-year follow-up, voiding dysfunction was reported in Group A: 9 and Group B: 8 patients (p = 0.056), de novo OAB was significantly reported in Group A: 23 and Group B: 26 patients (p = 0.007). Conclusion: Preoperative abdominal straining was found to be related to a significant incidence of de novo OAB. A significant correlation was not assessed for postoperative voiding dysfunction. Further studies may better define the impact of preoperative abdominal straining. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results